These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3889078)

  • 1. Monoamine oxidase inhibitors in the treatment of atypical depression.
    Zisook S; Braff DL; Click MA
    J Clin Psychopharmacol; 1985 Jun; 5(3):131-7. PubMed ID: 3889078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.
    Giller E; Bialos D; Harkness L; Riddle M
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):44-8. PubMed ID: 6376484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial of isocarboxazid in the treatment of bulimia nervosa.
    Kennedy SH; Piran N; Warsh JJ; Prendergast P; Mainprize E; Whynot C; Garfinkel PE
    J Clin Psychopharmacol; 1988 Dec; 8(6):391-6. PubMed ID: 3069879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An efficacy study of isocarboxazid and placebo in depression, and its relationship to depressive nosology.
    Davidson JR; Giller EL; Zisook S; Overall JE
    Arch Gen Psychiatry; 1988 Feb; 45(2):120-7. PubMed ID: 3276281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isocarboxazid in the treatment of depression.
    Zisook S
    Am J Psychiatry; 1983 Jun; 140(6):792-4. PubMed ID: 6342428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of isocarboxazid on blood pressure and pulse.
    Davidson J; Turnbull CD
    J Clin Psychopharmacol; 1986 Jun; 6(3):139-43. PubMed ID: 3519694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM; Stewart JW; McGrath PJ; Tricamo E; Rabkin JG; Ocepek-Welikson K; Nunes E; Harrison W; Klein DF
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
    Amsterdam JD; Bodkin JA
    J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response of depressed inpatients to isocarboxazid.
    Davidson J; Lipper S; Pelton S; Miller RD; Hammett EB; Mahorney S; Varia IM
    J Clin Psychopharmacol; 1988 Apr; 8(2):100-7. PubMed ID: 3372704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse, side effects, and monoamine oxidase inhibition during long term use of isocarboxazid: a case report.
    Davidson J; Sullivan JL
    J Clin Psychopharmacol; 1983 Feb; 3(1):42-3. PubMed ID: 6833523
    [No Abstract]   [Full Text] [Related]  

  • 11. MAO inhibitor therapy in trichotillomania associated with depression: case report.
    Krishnan RR; Davidson J; Miller R
    J Clin Psychiatry; 1984 Jun; 45(6):267-8. PubMed ID: 6725219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nomifensine in the treatment of depressed geriatric patients.
    Goldstein SE; Birnbom F; Laliberte R
    J Clin Psychiatry; 1982 Jul; 43(7):287-9. PubMed ID: 7045090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine in the treatment of Major Depressive Disorder: a comparison of efficacy in patients with and without melancholic features.
    Mallinckrodt CH; Watkin JG; Liu C; Wohlreich MM; Raskin J
    BMC Psychiatry; 2005 Jan; 5():1. PubMed ID: 15631624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of appetite and weight associated with the monoamine oxidase inhibitor isocarboxazid.
    Davidson J; Turnbull C
    J Clin Psychopharmacol; 1982 Aug; 2(4):263-6. PubMed ID: 7119133
    [No Abstract]   [Full Text] [Related]  

  • 15. Brofaromine in depression: a Canadian multicenter placebo trial and a review of standard drug comparative studies.
    Chouinard G; Saxena BM; Nair NP; Kutcher SP; Bakish D; Bradwejn J; Kennedy SH; Sharma V; Remick RA; Kukha-Mohamad SA
    Clin Neuropharmacol; 1993; 16 Suppl 2():S51-4. PubMed ID: 8313397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase inhibitor-responsive depression.
    Giller E; Bialos D; Riddle M; Sholomskas A; Harkness L
    Psychiatry Res; 1982 Feb; 6(1):41-8. PubMed ID: 7036196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Side effects of isocarboxazid.
    Zisook S
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):53-8. PubMed ID: 6376485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How best to identify a bipolar-related subtype among major depressive patients without spontaneous hypomania: superiority of age at onset criterion over recurrence and polarity?
    Benazzi F; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):77-88. PubMed ID: 17854907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.